Faculty

Richard N. Bergman, PhD
Keck Professor of Medicine and Chair
Department of Physiology and Biophysics
Keck School of Medicine of the University of Southern California (USC)
Los Angeles, California
Dr. Bergman is an internationally known expert in obesity and diabetes research. He holds an undergraduate degree in Engineering from Case Western Reserve University and a Ph.D. in Physiology from the University of Pittsburgh. Professor Bergman has contributed important research for over 30 years, and has published approximately 300 articles. He is the Keck Foundation Chair in Medicine at the University of Southern California, and has been Professor and Chairman of Physiology/Biophysics for 15 years. He introduced the "minimal model" approach to assessment of metabolic function and risk for disease. The clinical test using this model provides the "disposition index," which is the most powerful predictor of type 2 diabetes. He and his colleagues introduced a unique model of canine obesity to examine the interrelationships among obesity, insulin resistance, and diabetes. Dr. Bergman has won numerous honors for his work, including the "Outstanding Diabetes Investigator (Lilly Award)" from the American Diabetes Association, and the "TOPS" award from the Obesity Society (NAASO). He has delivered numerous prestigious lectureships, including the Mosenthal Lectureship, the Schwartz Lectureship, and the Berson Lectureship. In 2006, Dr. Bergman was awarded the Banting Medal from the American Diabetes Association. He is a well-regarded musician in the blues genre and performed at the opening session of the Obesity Society (NAASO) in 2004. He has been married for 39 years to Ronni, a Pediatric Nurse Practitioner; they have 2 grown children and 5 grandchildren.

Andrew J.M. Boulton, MD
Professor of Medicine
Universities of Manchester
Manchester, United Kingdom, and Miami, Florida
Professor Boulton graduated (with honors) from the University of Newcastle-upon-Tyne Medical School. He was subsequently a research fellow under Professor J.D. Ward in Sheffield, and Visiting Professor at the University of Miami prior to accepting an appointment at the Manchester Royal Infirmary. Professor Boulton has written more than 350 peer-reviewed manuscripts and book chapters, mainly on diabetic neuropathy and foot complications. He was the principal invited lecturer at the launch of the American Diabetes Association’s Foot Care Council. Among his many awards, he has been honored by receiving the American Diabetes Association's Roger Pecoraro Lectureship, the EASD Camillo Golgi prize for his contribution to worldwide care of the diabetic foot. He was the first recipient of the international award on diabetic foot research and is the 2008 winner of the ADA's Harold Rifkin award for distinguished international service in the field of diabetes.
He was the founding Chairman of the Diabetic Foot Study Group, was previously Chairman of Postgraduate Education and then program chair for the European Association for the Study of Diabetes (EASD), and was chair of the ADA foot wound interest group through 2007. He is currently director of extra-European postgraduate education and training for the EASD as well as an associate editor for Diabetes Care.

Darren K. McGuire, MD, MHSc
Associate Professor of Medicine
UT Southwestern Medical Center at Dallas
Dallas, Texas
Dr. McGuire received his undergraduate degree from Hendrix College in Conway, Arkansas, and his medical degree in 1993 from the Johns Hopkins University School of Medicine, at which time he was inducted into the AOA medical honor society. He was a resident in internal medicine and cardiology research fellow at the University of Texas Southwestern Medical Center at Dallas. He received his clinical cardiology training at Duke University, where he also spent 2 research years at the Duke Clinical Research Institute (DCRI) working on a number of large-scale international clinical trials. He served as the DCRI Chief Fellow 1999 - 2000, and during his research years, obtained a Master’s Degree in Health Sciences--Clinical Trials from the Duke University School of Medicine.
In August 2001, Dr. McGuire joined the cardiology faculty at UT-Southwestern where he is currently Associate Professor of Medicine, Associate of the Donald W. Reynolds Cardiovascular Clinical Research Center, Associate Director of the UT Southwestern Internal Medicine Residency training program, and Director of the Parkland Hospital and Health System Outpatient Cardiology clinic. His main clinical and research interests are in the long-term prevention of and risk-modification for cardiovascular disease, especially among patients with diabetes. He is actively involved in studying the effects of a number of therapeutic intervention strategies among patients with diabetes and cardiovascular disease, and is a Trustee and Founding Member of the International Society of Diabetes and Vascular Disease.

Oluf Pedersen, MD, DMSCi
Professor of Molecular Metabolism
Centre Director of Research
Chief Physician
University of Copenhagen
Oluf Pedersen was born in 1945 and graduated MD in 1972, the same year he received the gold medal for highest academic standing from the University of Aarhus, Denmark. In 1983 he defended his doctoral degree (Dr Med Sci) at the same university. He received his specialist training at university hospitals in Aarhus and was authorized as a specialist in endocrinology and internal medicine in 1987.
He has been a visiting professor at Beth Israel Hospital, Joslin Diabetes Center, and the Dana-Farber Cancer Institute in Boston. In 1995 he was appointed professor of molecular diabetology (personal chair) at the University of Copenhagen, and since 2001 he has held the same position at the University of Aarhus. In 2007 he was appointed director of the Lundbeck Foundation Centre of Applied Medical Genomics and this year he was appointed professor of molecular medicine at the Chinese Academy of Medical Science. He has mentored 28 academics who have defended their PhD or Dr Med Sci degrees and 36 graduate students who have achieved their master’s degrees under his supervision.
Since becoming chief physician and director of research at Steno Diabetes Center in Copenhagen in 1989, Dr. Pedersen has been supervising a research environment of 25+ people engaged in studies of metabolism and the molecular pathogenesis of metabolic disorders as well as interventional trials as exemplified by the landmark Steno-2 study, an example of successful application of basic research to clinical medicine. For the past 12 years, he has also played an instrumental role in the educational activities of Steno Diabetes Center, which offers 13 international postgraduate, state-of-the-art courses every year in various parts of the world.
Dr. Pedersen has been a pioneer in molecular endocrinology and his research group has contributed to multiple discoveries within the fields of adipocyte growth and development, insulin action, glucose transport and metabolism, energy metabolism, appetite regulation, and the molecular genetics of obesity, diabetes, hypertension, and dyslipidemia. He has written 352 original papers published in peer-reviewed journals and reviewed 80+ papers, editorials, and textbook chapters.
His research on molecular genetics of metabolic disorders is supported by grants from the Danish National Council of Health Science and the European Union. He has served as chairman or member on both national and international boards of scientific societies, councils, and grant bodies. From 1994 through 2000 he served as president of the Danish Diabetes Association, and currently sits on the editorial board of two international scientific journals.
Dr. Pedersen is knighted by Queen Margrethe II.